Finance

Beta
Lists
INNO:CNSX
Innocan Pharma Corp
CA$3.60
+10.77%
(+0.35) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for INNO...
Open
CA$3.60
High
CA$3.60
Low
CA$3.60
Mkt. cap
16.20M
Avg. vol.
686.00
Volume
200.00
52-wk high
CA$21.00
52-wk low
CA$3.01
EPS
-CA$0.47
No. of employees
8
Open
CA$3.60
High
CA$3.60
Low
CA$3.60
Mkt. cap
16.20M
Avg. vol.
686.00
Volume
200.00
52-wk high
CA$21.00
52-wk low
CA$3.01
EPS
-CA$0.47
No. of employees
8
News stories
From sources across the web
About Innocan Pharma Corp
CEO-
Employees8
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteinnocanpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.01M
6.82M
4.99M
6.46M
Cost of goods sold
811.00K
631.00K
558.00K
575.00K
Cost of revenue
811.00K
631.00K
558.00K
575.00K
Research and development expenses
176.00K
415.00K
161.00K
184.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.62M
6.99M
5.19M
6.49M
Operating expense
5.80M
7.41M
5.35M
6.68M
Total operating expenses
6.61M
8.04M
5.91M
7.25M
Operating income
396.00K
-1.22M
-922.00K
-786.00K
Other non operating income
-327.00K
-200.00K
1.93M
7.00K
EBT including unusual items
-109.00K
-1.43M
1.59M
-822.00K
EBT excluding unusual items
-17.00K
-1.30M
1.00M
-786.00K
Income tax expense
206.00K
220.00K
-262.00K
64.00K
Effective tax rate
-188.99%
-15.36%
-16.45%
-7.79%
Other operating expenses
-
-
-
-
Net income
-590.00K
-1.95M
2.00M
-972.00K
Net profit margin
-8.42%
-28.54%
40.00%
-15.03%
Earnings per share
-
-
-
-
Interest and investment income
-
7.00K
-
-
Interest expense
-4.00K
-
-3.00K
-7.00K
Net interest expenses
-4.00K
7.00K
-3.00K
-7.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
405.00K
-1.21M
-910.00K
-778.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer